Výsledky vyhledávání - "J, Manero Ruiz"

Akademický článek

Indicación y resultados del tratamiento quirúrgico y rehabilitador en la ráfaga cubital reumática muy avanzada

Autor: G. Martínez Villén, I. Herráiz Gastesi, E. García y García, F. J. Manero Ruiz, A. Herrera Rodríguez

Publikováno v: Revista Iberoamericana de Cirugía de la Mano, Vol 37, Iss 02, Pp 073-080 (2009)

La ráfaga cubital de la mano es una deformidad que afecta a más del 36% de los pacientes con artritis reumatoide. Los motivos para la indicación quirúrgica son controvertidos. Se han descrito numerosos procedimientos para la reconstrucción de pa

Externí odkaz: https://doaj.org/article/c58a12bd271d430e969e10a1f2eb3a20

Zobrazit plný text záznamu

POS0940 FACTORS ASSOCIATED WITH LONG-TERM RETENTION OF TREATMENT WITH GOLIMUMAB IN A LARGE COHORT OF PATIENTS WITH RHEUMATIC DISEASES, WITH UP TO 8 YEARS OF FOLLOW-UP

Autor: M. Pombo-Suarez, D. Seoane-Mato, L. Cea-Calvo, F. Diaz-Gonzalez, F. Sánchez-Alonso, M. Sánchez-Jareño, F. J. Manero Ruiz, L. Ruiz, V. Jovani, I. Castrejon

Publikováno v: Annals of the Rheumatic Diseases. 81:773-774

BackgroundThe long-term retention rate of a biological drug is a surrogate marker of its effectiveness and tolerability.ObjectivesWe assessed the probability of golimumab retention (persistence or drug survival) and the associated factors in a large

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fd57b2a941ccf283e33c8fbe30fe0e1a
https://doi.org/10.1136/annrheumdis-2022-eular.2429

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?

Autor: Clara Pérez Velásquez, Sergio Machín García, Carlos Montilla, Paloma García de la Peña Lefebvre, Iñigo Rúa-Figueroa, Beatriz Tejera Segura, Alejandro Olivé-Marqués, Mariano Andrés, Raúl Menor-Almagro, José L. Andreu, Jaime Calvo, Inmaculada Jiménez, Víctor Quevedo-Vila, Blanca Hernández-Cruz, Mercedes Freire, Tatiana Cobo-Ibáñez, Francisco J Manero-Ruiz, Natividad del Val del Amo, José M. Pego-Reigosa, Antonio Fernández-Nebro, J.G. Ovalles-Bonilla, Eva Tomero, María Luisa Velloso-Feijoó, Lorena Expósito, Eva Salgado, Clara Moriano, Alina Boteanu, Natalia Pérez Veiga, Irene Altabás González, Nuria Lozano-Rivas, Tomas R. Vazquez-Rodriguez, Jesús Ibañez-Rua, Victor Del Campo Pérez, Esther Uriarte Isacelaya, Marta Arévalo, María José Galindo, Jose Miguel Senabre Gallego, Víctor M. Martínez-Taboada, Ana Paula Cacheda, Gema Bonilla, Javier Narváez, Atusa Movasat

Publikováno v: Rheumatology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Rheumatology (Oxford) . 2021 Nov 3;60(11):5329-5336
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
Zaguán. Repositorio Digital de la Universidad de Zaragoza
RHEUMATOLOGY
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
r-FISABIO. Repositorio Institucional de Producción Científica

Objective SLE can affect any part of the gastrointestinal (GI) tract. GI symptoms are reported to occur in >50% of SLE patients. To describe the GI manifestations of SLE in the RELESSER (Registry of SLE Patients of the Spanish Society of Rheumatology

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b975c73b48f04871c38354aba016b4c0
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4324

Zobrazit plný text záznamu

AB0758 Golimumab after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases: four-year retention rate in the Spanish BIOBADASER registry

Autor: M. Pombo-Suarez, D. Seoane-Mato, F. Diaz-Gonzalez, F. Sánchez-Alonso, L. Cea-Calvo, M. Sánchez-Jareño, V. Jovani, P. Pretel, F. J. Manero Ruiz, I. Castrejon

Publikováno v: Annals of the Rheumatic Diseases. 81:1504.2-1505

BackgroundTreatment options for rheumatic diseases have evolved to include mechanisms of action beyond tumor necrosis factor inhibitors (TNFi). While non-TNFi biologics and targeted synthetic disease-modifying antirheumatic drugs (tsDMARDS) have been

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8b655c9b5e6a21bb8481f0efc54604ae
https://doi.org/10.1136/annrheumdis-2022-eular.1560

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

FRI0185 Are There Differences in Baseline Characteristics of Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors According To The Presence of Comorbidities?: Table 1

Autor: R. Rosello Pardo, J.J. Gόmez-Reino, J. Manero-Ruiz, JA Gόmez-Puerta, Fernando Sánchez-Alonso, Eva Perez-Pampin, Carlos Sánchez-Piedra, Eduardo Cuende, Mirtha Hernández, Raimon Sanmartí, Carlos Rodríguez-Lozano

Publikováno v: Annals of the Rheumatic Diseases. 75:497.1-497

Background Rheumatoid arthritis (RA) is often associated with comorbidities that may affect the therapeutic choice or a different management in clinical practice. It is unclear whether patients with comorbidities have a different profile from those w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::07e9401262c89ac7012ae82853a74405
https://doi.org/10.1136/annrheumdis-2016-eular.5799

Zobrazit plný text záznamu

AB0361 Evaluation of Baseline Characteristics of Rheumatoid Arthritis Patients Treated with Abatacept or Tumor Necrosis Factor Inhibitors in Clinical Practice in Spain

Autor: J. Manero-Ruiz, Raimon Sanmartí, Fernando Sánchez-Alonso, Carlos Rodríguez-Lozano, R. Rosello Pardo, Juan D. Cañete, Eva Perez-Pampin, Juan J. Gomez-Reino, A. Ortiz-García, Carlos Sánchez-Piedra, Mirtha Hernández

Publikováno v: Annals of the Rheumatic Diseases. 75:1027.1-1027

Background Biological therapies have demonstrated efficacy in patients with rheumatoid arthritis (RA) improving the prognosis. The most widely used biological agents are tumor necrosis factor inhibitors (TNFi), although other biological agents with d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::52fc0a4f3dee45ff720e738d0e90964d
https://doi.org/10.1136/annrheumdis-2016-eular.4551

Zobrazit plný text záznamu

[Bone Paget's disease in the young adult]

Autor: F J, Manero Ruiz, A, Urruticoechea Arana, M, Medrano San Ildefonso, A, Pecondón Español

Publikováno v: Revista clinica espanola. 204(10)

Bone Paget's disease (BPD) is a focal disorder of bone remodeling of unknown etiology that affects mainly patients older than 50 years. BPD is after osteoporosis the most frequent osteopathy of the western world and was described for the first time i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6e023c264b8cc94390a283383019cce2
https://pubmed.ncbi.nlm.nih.gov/15456600

Zobrazit plný text záznamu

[Spinal pseudoarthrosis in ankylosing spondylitis]

Autor: F J, Manero Ruiz, M, Roca Espiau, J, Mota Martínez

Publikováno v: Anales de medicina interna (Madrid, Spain : 1984). 19(9)

Spinal pseudoarthrosis is an uncommon complication in patients with advanced ankylosing spondylitis which consists in destruction of the discovertebral junction. Two cases of spinal pseudoarthrosis at the thoracolumbar level after a spontaneous fall

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::df50d5a139d5892440e7424d0b6bb7b5
https://pubmed.ncbi.nlm.nih.gov/12420633

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání